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Background: Vertebral fractures could lead to reduced physical, social and mental functioning, and loss of personal
independence. Therefore, during the treatment of osteoporosis, it has become necessary to examine the changes
in everyday functioning, well-being and health related quality of life (HRQOL). To that effect, this study aims to
translate, culturally adapt, and validate the Serbian version of Quality of Life Questionnaire of the European
Foundation for Osteoporosis (QUALEFFO-41) for patients with vertebral fractures.
Methods: Nine female patients with osteoporosis participated in the pre-validation study. A validation, case–control
study included two groups of female patients: one that consisted of 50 female patients with osteoporosis, and with
at least one vertebral fracture, and another one that consisted of 50 control patients with osteoporosis but without
fractures. They completed the QUALEFFO-41 and the EuroQol group questionnaire with five dimensions (EQ-5D)
twice within a month. The validation study examined internal consistency, concurrent validity, test-retest reliability,
sensitivity and specificity.
Results: During the pre-validation study, three of the items in the QUALEFFO-41 were slightly changed. Afterwards,
during the validation study, the statistically significant differences (adjusted for: age, duration of menopause, current
employment and marital status) in the mean values of all domains and total scores between the groups were
noted. For the case group, the internal consistency of the QUALEFFO-41 domains and of total questionnaire was
above 0.70. The test-retest reliability was tested by the intraclass correlation coefficients (ICC) that were in range
0.87 – 0.96 for the case, and 0.15 – 0.83 for the control group. Correlations between the total scores of the
QUALEFFO-41 and the EQ-5D health state value, for both groups were negative and statistically significant (r = -0.78,
p<0.001 and r = -0.73, p<0.001, respectively). The QUALEFFO-41 had a better prediction of the value of HRQOL of
cases compared to the generic questionnaire EQ-5D (the AUC difference was 0.099, p = 0.013).
Conclusions: The Serbian QUALEFFO-41 version is reliable, valid, sensitive and predictive for examinations of
HRQOL in patients with prevalent vertebral fractures and can be used in further studies.
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The most common fractures in osteoporosis are the verte-
bral ones [1]. If at least one vertebral fracture exists, the
risk of the new ones is fivefold higher during the initial
year [2]. These fractures can cause back pain, kyphosis,
difficulties in performing daily activities, depression and
anxiety, all of which can be reflected in physical, social
and mental functioning and loss of personal independence
[3-7]. Severity of these symptoms is related to the degree
of deformity and the number of fractures. In average, back
pain remains almost the same five years after the diagnosis
of the vertebral fractures has been established, while key
physical functions of independent living could deteriorate
[4]. The treatment progress of patients with vertebral frac-
tures should not be based only on the clinical outcomes,
but on the humanistic ones as well, such as the health
related quality of life (HRQOL) outcome.
According to the literature, the Quality of Life Ques-
tionnaire of the European Foundation for Osteoporosis
(QUALEFFO-41) is the most frequently used question-
naire for measuring the HRQOL of patients with osteo-
porosis and vertebral fractures [8-15]. The QUALEFFO-
41 is specific, sensitive, and questionnaire which are able
to discriminate between patients with and without verte-
bral fractures [16]. It is shown that the questionnaire is
sensitive to the number of fractures. The QUALEFFO-41
score decreases with increasing number of vertebral frac-
tures [5,9].
This questionnaire covers main aspects of quality of life:
pain, physical functions, social functions, general health
and mental health [15]. There are several versions of the
questionnaire: the first one had 48 items and it was
shortened to 41 items [17]. A short version, with 31 items,
also exists [18]. The QUALEFFO-41 is still the most ap-
plied questionnaire in different studies and cultures
[7,15,17-21].
There has been no previously validated specific HRQOL
questionnaire for osteoporosis with vertebral fractures in
Serbia. Therefore, the aim of this study is to examine psy-
chometric properties and validate the Serbian version of
QUALEFFO-41. As we cannot compare the results of this
one to other specific questionnaires, a generic question-
naire the EuroQol group questionnaire with five dimen-
sions (EQ-5D) previously translated and culturally adapted
for Serbian population was used [22].
Methods
This is a case–control study conducted during the period of
June 2010 - October 2011. The study was performed in two
medical centres: The Institute of Rheumatology - Medical
Faculty, University of Belgrade and The Institute for Pre-
vention and Treatment of Rheumatic Diseases “Niska
Banja”, Medical Faculty University of Nis. The study was
approved by the Ethics Committees of both institutes.All patients were recruited by their physicians. Patients
who agreed to participate provided a written informed
consent before enrolment. The QUALEFFO-41 and the
EQ-5D were administered within one month. The ques-
tionnaires have always been administrated in the same
order: QUALEFFO-41 followed by the EQ-5D. First,
patients completed a set of the questionnaires during
regular clinical visits without help from the medical staff
or family members. At this time, one more set of the ques-
tionnaires was given to every patient. Afterwards, approxi-
mately one month later, they were reminded by phone to
complete the set of the questionnaires again, and to send
them back by mail to the main researcher (T.I.).Participants
The patients with osteoporosis participated in the pre-
validation study (translation and cultural adaptation of
the QUALEFFO-41 questionnaire). Responses of these
patients were not considered in the validation study.
The validation study was conducted with patients suffer-
ing from osteoporosis with at least one vertebral fracture
(case group), and the control group of patients with osteo-
porosis and with no fractures. Main inclusion criteria for
both groups were the same: postmenopausal women over
45 years of age, with primary osteoporosis, who were able
to read and write Serbian language. The following exclusion
criteria were also applied: presence of chronic back pain
caused by other diseases, inflammatory rheumatic disease,
malignant or metabolic bone diseases, and usage of gluco-
corticoids. Patients with incidental vertebral fractures dur-
ing the one month period prior to the study were excluded.
Sample size was calculated as a number of patients
needed for paired t-test (to test the difference in results
between the case and the control group). For α= 0.05
and 80% power of detection 33 patients in each group
are needed [23]. This study also tested reproducibility of
the questionnaire. A sample size, needed to detect the
differences in patients’ agreements, had to be at least 50
[24]. Therefore, up to 50 eligible patients meeting the
criteria were included for each group.Diagnosis of osteoporosis and vertebral deformity
measurement
Primary osteoporosis was diagnosed by Dual-energy X-
Ray Absorptiometry (DXA) measurement on the lumbar
spine (L1-L4) and/or the hip. The DXA measurement was
performed using the GE Lunar Prodigy, according to the
World Health Organization criteria [25]. Fractures were
defined according to the Genant's classification (vertebral
anterior, middle or posterior height reduction more that
20%) [1]. Vertebral deformities were established by the
lateral radiography of the thoracic and lumbar regions
(T4-L5) by an experienced radiologist.
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questionnaire
The translation and the cultural adaptation of the
QUALEFFO-41 were performed according to the Inter-
national Society for Pharmacoeconomics and Outcomes
Research guidelines [26]. First, permissions to use the
questionnaires were obtained from the copyright holders
(for the EQ-5D-Serbian version from the EuroQol group
and for the QUALEFFO-41 from the International Osteo-
porosis Foundation). Then, three authors T.I., S.D. and V.
S.N. participated in the forward translation process and
made three independent English – Serbian QUALEFFO-
41 translations (“T1”, “T2” and “T3”). All translators (na-
tive Serbian speakers) were familiar with the topic and the
research concept. Through discussions between them, the
new version “T123” was created as a result of merging all
of the translated versions. In the process of back translat-
ing, two independent translators, who were not familiar
with the research concept, translated version T123 back
into English (versions “B1” and “B2”). The original
QUALEFFO-41 questionnaire, the forward and backward
translated versions, were reviewed and compared in orderValidation study (case-contro
Pre
T
Obtain
Translation and cultural adaptation
questionnaire 
Me
Back
Th
All tra
Crea
Potential new Serbian version of the QU
The final Serbian version of the QUALEFFO
Figure 1 The translation and cultural adaptation process of the QUALto check the conceptual equivalence. During the last phase
(cognitive debriefing), the questionnaire was pre-tested on
a sample of osteoporosis patients. This group of patients
was chosen irrespectively of presence of vertebral frac-
tures. After the patients had completed the questionnaire,
they were asked to comment on the simplicity, clarity and
relevance of the items. Translation, cultural adaptation
and validation steps were summarized on the Figure 1.
Questionnaires
The QUALEFFO-41 is a self-administered, disease specific
questionnaire [15]. Most of the items were developed by
the clinicians of the Working Party of the European Foun-
dation for Osteoporosis and two were taken from the
Mediterranean Osteoporosis Study (MEDOS) Question-
naire and European Vertebral Osteoporosis Study (EVOS)
Questionnaire [17]. It possesses five domains (41 items in
total): pain (5 items), physical function (17 items), social
function (7 items), general health perception (3 items) and
mental function (9 items). Most of the items have 5 an-
swer options. Exceptions have been made for the items
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order (the minimum number on the scale is assigned to
the best answer and the maximum to the worst answer),
except for the items No 33, 34, 35, 37, 39 and 40. The
score of each domain is calculated as an average value of
all the answered items linearly transformed on a scale 0-
100. The total QALEFFO score is calculated as a sum of
all answers to items and then linearly transformed on the
scale 0-100. The worse the HRQOL condition is, the
higher the score gets. The scoring algorithm is made in a
way to calculate the total score proportionally to the
answered items (when a missing value is present, the cal-
culations are corrected according to the number of miss-
ing values). According to the scoring algorithm the
missing value should not have exceeded 30%, otherwise
the domain or the total score becomes inaccurate.
The EQ-5D is a self-administered, general questionnaire
and can be used in various population groups. The EQ-5D
consists of two parts: a self-reported 5-item questionnaire
and a visual analogue scale (VAS). All items have 3 answer
options. The EQ-5D health state value (HSV) is calculated
according to the user manual [27,28]. The EQ-5D HSV
ranges from 0 (the worst possible HRQOL condition) to 1
(the best possible HRQOL condition). The VAS is a 100
degree thermometer - like scale that represents the
current health state. The VAS score is defined as the value
that patients mark on the scale at the place that reflects
their current health state the best.Statistical analysis
Patients’ demographics and clinical data were collected dur-
ing the inclusion of patients. They included: age, age at
menopause onset, employment and marital status, educa-
tion level, number of fractures and fracture site. The de-
scriptive analysis included calculation of mean, SD,
distribution of missing data, floor and ceiling effects. This
analysis was performed for both groups, and it was calcu-
lated for all domains and total scores. The ceiling effects
represent a percentage of the highest possible scores, op-
posite to the floor effects. The presence of high values of
the floor or ceiling effects could indicate poor discrimin-
ation of items and thus reduced sensitivity of the question-
naire [29]. The floor and ceiling effects should be less than
15%, if a scale encompasses the entire range of possible
responses [24]. Differences between the demographic char-
acteristics of groups were tested using t-test. Differences be-
tween the mean values of the domain scores of the groups
were tested using ANCOVA. The test was adjusted for all
the variables that were shown to be significantly different
between the groups.
Internal consistency was assessed using the Cronbach’s
α coefficient. The Cronbach’s α value should be greater
than 0.7 for a scale of good consistency [30].Pearson’s correlation coefficient was calculated between
all the items and their domain score to check item’s con-
vergent validity. The correlation coefficient should be
moderate to large (≥0.4). A discriminant validity checks if
the item measures other concept that it is not supposed to
measure. A degree of item’s discriminant validity was cal-
culated as a correlation between items and scores of other
domains. The discriminant validity of each item should be
lower than the convergent one [29].
Reproducibility was estimated through a test-retest after
one month. The strength of agreement between the
repeated measures was examined using the intraclass cor-
relation coefficient (ICC). The recommended value of ICC
is ≥0.7, but it is considered as acceptable if it is≥ 0.6 [29].
Concurrent validity was explored by correlations be-
tween the scores of the QUALEFFO-41 and EQ-5D ques-
tionnaires. Since the EQ-5D has only five items, a
correlation coefficient was calculated only between the
total score of the QUALEFFO-41 and the EQ-5D HSV.
Finally, the sensitivity was assessed by the Receiver Op-
erating Characteristics Curve (ROC) analysis. This analysis
can describe discrimination ability of a questionnaire. The
ROC is defined by the values of sensitivity (true positive
rate) and specificity (true negative rate) of the question-
naire. Sensitivity is an ability of a questionnaire to detect a
patient with the observed disease versus specificity (that is
the ability to detect a patient without the disease). This
analysis included comparison of the areas under the ROC
curves (AUC) over all possible cut-off values of the ques-
tionnaire’s scores [15,31,32]. A sensitive questionnaire
should have AUC values above≥ 0.7 [24].
Statistical analyses were performed using Statistical
Package for Social Sciences (SPSS) version 18.0 and Med-
Calc package version 11.6.1.
Results
Nine female patents participated in the pre-validation
study. Two of them were with osteoporosis and with
vertebral fractures. The average age of the patients was
64.89 years (SD= 3.48).
No item was replaced or omitted from the QUALEFFO-
41-The Serbian Version in the pre-validation study.
According to the patients’ opinions, most of the items
were understandable, clear, precise, and relevant to the
HRQOL assessments. Only three of the items were slightly
changed. In the item No 26 (“Can you visit a cinema, the-
atre, etc.?”) one more answer (“No financial means for that
activity”) was added in accordance with patients’ opinions.
This change did not have an effect on the scoring of the
social function domain. In the item No 14 (“Can you lift a
heavy object of 20 lbs (e.g. a crate of 12 bottles of milk, or
a one year old child), and carry it for at least 10 yards?”)
Anglo-Saxon units were converted into the International
System of Units (SI) (lbs into kg, and yards into metres).
Table 1 Socio-demographic and clinical characteristics of
the case and control subjects
Cases
(n = 50)
Controls
(n = 50)
p-value
Age mean in years (SD) 71.84 (8.57) 63.02 (7.49) p< 0.001
Mean age of menopause
onset (SD)
47.10 (5.13) 47.02 (5.36) 0.93
Duration of menopause
in years (SD)
24.74 (8.98) 16.00 (9.62) p< 0.001
BMI mean (kg/m2) (SD) 25.14 (4.53) 25.71 (3.76) 0.50
Employment status (N, (%)) 0.01
Working 1 (2.00) 7 (14.00)
Not working 5 (10.00) 10 (20.00)
Medical leave of absence 2 (4.00) 0 (0.00)
Retired 42 (84.00) 33 (66.00)
Education level (N, (%)) 0.62
No formal education 0 (0.00) 2 (4.00)
Primary 18 (36.73) 15 (30.00)
Secondary 11 (22.45) 22 (44.00)
Master degree 18 (36.73) 10 (20.00)
Postgraduate 2 (4.08) 1 (2.00)
Marital status (N, (%)) p< 0.001
Married 18 (36.00) 38 (76.00)
Single (including divorced) 8 (16.00) 3 (6.00)
Widowed 24 (48.00) 9 (18.00)
SD, Standard Deviation
BMI, Body Mass Index
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the living conditions in Serbia (“Can you climb stairs to
the next floor of a house” was replaced with “Can you
climb stairs to the next floor”). This replacement did not
affect the meaning of the item, and the item still conceptu-
ally corresponds to the physical function domain.
Subjects
In the validation study, 110 female patients were recruited
(52 cases and 58 controls). Two of the patients in the case
group did not meet the inclusion criteria (response rate
for the case group was 96.15%). Seven of the patients in
control group did not return the questionnaires at the ini-
tial recruitment, and one of them did not meet the inclu-
sion criteria (response rate for the control group was
86.21%). After one month, 80% of cases and 52% of con-
trols completed and sent-back the set of questionnaires.
Average time between the first and the second assessment
was 30.40 days (SD=9.51) for the cases and 32.48 days
(SD=11.29) for the controls. At the initial assessment, it
took patients approximately fifteen minutes to complete
the set of questionnaires.
In average 2.12 (SD= 1.70, range 1-9) vertebral frac-
tures were noted in the case group. Patients usually had
one vertebral fracture (55.10%) and the most frequent
fracture was located at the L1 vertebra (24.04%). Infor-
mation about the number and the site of fractures are
provided in additional files [see Additional file 1] [see
Additional file 2].
Significant differences between the groups were found
regarding the age, the duration of menopause, the employ-
ment, and the marital status (Table 1). These variables were
included as the controlling ones in the analyses below.
Descriptive statistics
Between the groups, the differences (adjusted for the
age, the duration of the menopause, the current employ-
ment and the marital status) in the mean values for all
domains and total scores were statistically significant.
The number of missing values for both groups was
below 5.2%. An exception in the case group was noted
for the social function domain (22%).
A floor effect above 15% was observed for the general
perception domain in both groups. High percentage value
(30%) of ceiling effect was noted in control group for the
pain domain. The difference in VAS scale between the
groups was consistent with the difference of HSV. But, the
difference of VAS mean values was not statistically signifi-
cant (p> 0.05) (Table 2).
The QUALEFFO-41 and EQ-5D
The Cronbach’s α value for the QUALEFFO-41 domains
ranged from 0.79 to 0.93 for the case and from 0.33 to0.92 for the control group. Cronbach’s α for the EQ-5D
was 0.84 for the case and 0.75 for the control group.
All the items correlated better with their own domain
score, than with the other domain scores.
Test-retest reliability in both groups was satisfactory
with all ICC values above 0.6, except for general health
perception domain in the control group (Table 3).
A correlation between the total score of the QUALEFFO-
41 and EQ-5D HSV was negative and statistically significant
(Spearman’s rank correlation coefficients for cases and con-
trols were r = -0.78, p<0.001 and r= -0.73, p<0.001,
respectively).
The ROC curve analysis indicated a modest ability of
QUALEFFO-41 to detect the difference in HRQOL scores be-
tween the case group of patients and the control ones
(Figure 2).
The AUC of the QUALEFFO-41 domains and the total
score showed poor discriminatory capacity (AUC range
0.62 – 0.69). However, the QUALEFFO-41, compared to
EQ-5D, could better predict the value of HRQOL in
patients with vertebral fractures (difference between
areas was statistically significant for p<0.05) (Table 4).
Table 2 Descriptive statistics of the QUALEFFO-41 and EQ-5D questionnaires
Questionnaire
domain
Mean (SD) Missing values inside domain (%) Floor (%) Ceiling (%)
Controls Cases Controls Cases Controls Cases Controls Cases
QUALEFFO-41
Pain 40.78 (32.58) 55.20* (26.22) 13 (5.20) 9 (3.60) 2.00 6.00 30.00 8.00
Physical function 23.65 (18.64) 42.56** (22.26) 10 (1.18) 14 (1.65) 4.00 4.00 10.00 2.00
Social function 52.15 (23.16) 67.70** (23.47) 10 (1.18) 77 (22.00) 8.00 6.00 2.00 2.00
General health perception 64.08 (19.69) 74.33* (21.68) 2 (1.33) 1 (0.67) 16.00 24.00 2.00 2.00
Mental function 28.40 (14.59) 38.10* (15.66) 4 (0.89) 8 (1.78) 2.00 2.00 2.00 4.00
Total QUALEFFO-41 score 35.71 (16.73) 51.86* (19.00)
EQ-5D
HSV 0.58 (0.20) 0.46* (0.28) 10 (4.00) 10 (4.00)
VAS scale 50.46 (23.21) 48.60 (21.54) 4 (8.00) 2 (4.00)
*P<0.05, **P<0.001, ANCOVA
SD, Standard Deviation
QUALEFFO-41, Quality of Life Questionnaire of the European Foundation for Osteoporosis
EQ-5D, EuroQol Group Questionnaire
HSV, Health State Value
VAS, Visual Analogue Scale
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This is the first study in Serbia in regards to reporting
on the validation of the osteoporosis specific HRQOL
questionnaire, the QUALEFFO-41. The results indicate
that the Serbian version of the QUALEFFO-41 has satis-
factory general psychometric characteristics.
The QUALEFFO-41 was well accepted by patients
who participated in the pre-validation study. Most of the
items, in accordance with the patients’ opinions, wereTable 3 Results of the multi-trait statistics of QUALEFO-41 do
Questionnaire/
domain
Cronbach's α (range of
Cronbach's α if item
deleted)
Range of item correla
coefficient with own dom
Controls Cases Controls Cas
QUALEFFO-41
Pain 0.82 (0.73-
0.87)
0.86 (0.81-
0.86)
0.21-0.92 (80.00) 0.69-0.88
Physical function 0.92 (0.91-
0.93)
0.93 (0.92-
0.94)
0.33-0.84 (94.12) 0.32-0.86
Social function 0.33 (0.08-
0.51)
0.80 (0.75-
0.80)
0.03-0.71 (57.14) 0.46-0.81
General health
perception
0.48 (0.12-
0.72)
0.81 (0.62-
0.89)
0.45-0.83 (100.00) 0.77-0.91
Mental function 0.74 (0.66-
0.75)
0.79 (0.74-
0.79)
0.39-0.79 (55.56) 0.37-0.81
Total QUALEFFO-41
score
0.91 (0.90-
0.92)
0.83 (0.75-
0.89)
EQ-5D
Health state value 0.75 (0.73-
0.88)
0.84 (0.83-
0.89)
-0.77- -0.56
(100.00)
-0.82-
(100
aA percent of correlation coefficients higher than 0.4
QUALEFFO-41, Quality of Life Questionnaire of the European Foundation for Osteop
EQ-5D, EuroQol Group Questionnairesimple, clear, and relevant to the HRQOL assessment,
and only three items underwent slight changes. In the
item No 26 “Can you visit a cinema, theatre, etc.?” the
answer “No financial means for that activity” was added.
This change is related to the living condition in Serbia,
where most of the retiree patients have had an average
retirement income of approximately 220EUR per month.
Changes in two more items (No 14 and No 18) were in
relation to the SI metric unites and the living conditionsmains and EQ-5D
tion
ain (%)a
Range of item correlation
coefficient with other
domains (%)a
Intraclass correlation
coefficient (n = 38)
es Controls Cases Controls Cases
(100.00) -0.21-0.47
(20.00)
0.15-0.55 (60.00) 0.78 (0.53-0.90) 0.87 (0.76-0.87)
(94.11) 0.03-0.69 (45.59)0.01-0.66 (76.47)0.83 (0.62 - 0.92) 0.94 (0.88-0.97)
(100.00) -0.29-0.60
(17.86)
-0.10-0.74
(50.00)
0.78 (0.52 - 0.90) 0.91 (0.82-0.95)
(100.00) -0.01-0.45
(25.00)
0.38-0.73 (91.67) 0.15 (-0.59 -
0.55)
0.91 (0.84-0.95)
(66.67) -0.01-0.62
(27.78)
0.01-0.65 (30.56)0.76 (0.47 - 0.89) 0.89 (0.80-0.94)
0.82 (0.60 - 0.92) 0.96 (0.92 -
0.98)
-0.66
.00)
orosis
Figure 2 ROC curve for QUALEFFO-41 domains and total score.
Discrimination between cases and controls.
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http://www.hqlo.com/content/10/1/74in Serbia. None of the aforementioned changes affected
the meaning of the items, the domains concepts and the
scoring of QUALEFFO-41.
The results of the general analysis showed the follow-
ing. The results of the missing value analysis indicated
that the most of the QUALEFFO-41 domains possess
good acceptability. However, the highest missing value
was found in the group of patients with vertebral frac-
tures regarding the social function domain. A possible
explanation could be related to the disability of patients
to engage in the sports activities, do the gardening, and
go to the cinema/theatre. Furthermore, the menopausal
women found the item: “Does your back pain or disabil-
ity interfere with intimacy (including sexual activity)?”-
too private to answer. This item, also a part of the social
function domain, could also be related to the level of
disability caused by vertebral fractures.
The floor and ceiling effects were acceptable in both
groups of patients. Only the general health perceptionTable 4 ROC curve analysis of questionnaires QUALEFFO-
41 and EQ-5D
QUALEFFO-
41 area (SE)
CI EQ-5D HSV
area (SE)
CI Difference
area (SE)
p-
value
Pain 0.62 (0.056) 0.52 -
0.72
Physical function 0.75 (0.049) 0.65 -
0.83
Social function 0.69 (0.052) 0.59 -
0.78
General health
perception
0.65 (0.055) 0.55 -
0.74
Mental function 0.67 (0.054) 0.57 -
0.76
Total QUALEFFO-
41 Score
0.74 (0.050) 0.65 -
0.82
0.64 (0.056) 0.54 -
0.74
0.099
(0.040)
0.013
ROC, Receiver Operating Characteristics
QUALEFFO-41, Quality of Life Questionnaire of the European Foundation for
Osteoporosis
EQ-5D, EuroQol Group Questionnaire
HSV, Health State Value
SE, Standard Error
CI, Confidence Intervaldomain had a high floor effect in the group of patients with
fractures, and the pain domain had a high ceiling effect in
the group of patients without the fractures. The patients
with fractures usually have pain and physical disabilities that
can influence their general health perception as of being
poor. This is in accordance with the fact that the osteopor-
osis can be asymptomatic until the fractures occur [33].
The patients without fractures haven’t had any back pain
and thus more readily choose more favourable responses in
the pain domain. Nevertheless, these results could indicate
that these two domains have a poor discrimination and thus
a reduced sensitivity and responsiveness.
The mean QUALEFFO-41 values were higher in the
patients with fractures than in the control group, as
opposed to the results of the EQ-5D HSV. Such a result
was expected, because the scoring of these two scales went
in the opposite directions. These results indicated that the
patients with fractures had poorer levels of HRQOL than
the patients without fractures. These results are in accord-
ance with a similar study [21].
Considering the psychometric properties of the Serbian
version of QUALEFFO-41, several important facts were
observed. In the group of patients with fractures, the values
of Cronbach’s α in all the QUALEFFO-41 domains were
higher than 0.70, indicating a good internal consistency.
Similar Cronbach’s α values were reported regarding other
language versions, e.g.: Arabic (range 0.74-0.89), Turkish
(range 0.70-0.90) and some European versions (range 0.72-
0.92) [15,20,21]. For the control group of patients, the in-
ternal consistency was also satisfactory regarding the overall
questionnaire and some of the domains, but in regards to
the social function and general health perception domains,
it was below 0.7. The study conducted on the Mexican
population reported a low Cronbach’s α value in the social
domain, even in the case group of patients (patients with
vertebral fractures). This study had tested both, the social
function domain including all seven items, as well as the
one excluding two items, and it showed that a shorter ver-
sion of the domain was more acceptable to be the part of
the questionnaire (Cronbach’s α value was 0.46 in the
seven-item domain and 0.71 in the five-item domain)[19].
Convergent validity was satisfactory for the group of
patients with fractures, with two exceptions: the low cor-
relation coefficient values were noted in the domains of
the physical and mental functions. Considering the group
of patients without fractures, only in the domain of the
general health perception, satisfactory correlation coeffi-
cient values, have been observed.
In both groups, the items were more convergent than
discriminant. These results indicated a good distribution
of items in the domains. According to these facts, the
items measured the same concept in each domain.
The strength of agreement between repeated measures in
the group of patients with fractures was satisfactory for all
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for the general health perception domain were below the
acceptable value. In addition, this domain has had a low in-
ternal consistency. It can be assumed that this domain is
not suitable to be a part of the questionnaire for the osteo-
porosis patients without fractures.
A concurrent validity was explored by correlations be-
tween QUALEFFO-41 and EQ-5D questionnaires and
the results showed that the questionnaires were highly
correlated and both measured the HRQOL aspects.
The AUC values indicated that QUALEFFO-41 had a
low to moderate power to discriminate HRQOL domain
scores of patients with and without vertebral fractures.
The study conducted in Mexico with the same type of
case–control patients has shown similar results (vales of
the AUC were in range from 0.52 to 0.73) [19]. Lips
et al. also reported equivalent results (values of the AUC
were in range from 0.64 to 0.78), for patients with verte-
bral fractures as a case group and healthy controls [15].
We expected to get lower AUC values compared to the
study reported by Lips et al., taking into account that we
included patients with lesser differences in health condi-
tions between the groups.
The AUC value of QUALEFFO-41 total score was
higher and significantly different than that of the EQ-5D
. Therefore, the QUALEFFO-41 has more power to pre-
dict the HRQOL in patients with vertebral fractures in
relation to the EQ-5D.
We have noted several limitations in our study. First, we
did not use another specific HRQOL questionnaire to
evaluate the concurrent validity, since there had been no
such previously validated questionnaire with similar
domains in Serbia. Second, we used a uni-dimensional gen-
eric questionnaire EQ-5D, so that we could make compari-
sons only between the total scores of questionnaires as an
external criterion. Third, we did not compare QUALEFFO-
41 scores of patients with different numbers of vertebral
fractures. Thus, the sensibility of the questionnaire to detect
differences in the HRQOL, according to the number of ver-
tebral fractures was left unexplored. Finally, the construct
validity was not evaluating using a factor analysis, either ex-
plorative or confirmatory, considering the small number of
patients. Further research should include larger number of
patients, which would allow us to use the factor analysis,
and thus complete the validation of the questionnaire.Conclusions
This study has shown that the Serbian version of the specific
osteoporosis questionnaire, QUALEFFO-41, has been well-
accepted by the patients. The questionnaire has an appropri-
ate internal consistency, test-retest reliability, sensitivity and
specificity. Thus, the Serbian QUALEFFO-41 version pos-
sesses satisfactory general psychometric characteristics and itcan be used in clinical studies on patients with vertebral
fractures.
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